Some provisions in the Inflation Reduction Act (IRA) that lower the cost of prescription drug costs, such as a cap on insulin costs, take effect in 2023. Rebates for costs exceeding inflation will begin in 2023. Drug negotiations for certain high-cost drugs won’t take effect until 2026.